NEI
MYGN icon

Northwest & Ethical Investments’s Myriad Genetics MYGN Stock Holding History

Northwest & Ethical Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-116,720
Closed -$2.74M – 238
2013
Q3 		$2.74M Hold
116,720
– – 0.2% 114
2013
Q2 		$3.14M Buy
+116,720
New +$3.38M 0.25% 89

Other funds holding MYGN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
LCG
Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return
MCM
Munder Capital Management Birmingham, Michigan $13.4B AUM 18.35% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.28B AUM 23.15% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northwest & Ethical Investments's MYGN Position: Q4 2013 in Review

Northwest & Ethical Investments sold out of Myriad Genetics (MYGN) in Q4 2013, closing a stake of 116,720 shares — an estimated $2.74M sold.

Northwest & Ethical Investments first reported a position in MYGN in Q2 2013 and held it in 2 quarters. The position peaked at $3.14M in Q2 2013. 270 funds tracked by Wall St. Rank hold MYGN as of Q4 2013.

  • Northwest & Ethical Investments reported no remaining Myriad Genetics position as of Q4 2013 after selling out during the quarter.
  • Northwest & Ethical Investments sold 116,720 Myriad Genetics shares in Q4 2013, an estimated $2.74M.
  • Northwest & Ethical Investments first reported a position in Myriad Genetics in Q2 2013 and held it in 2 quarters.
  • Northwest & Ethical Investments's Myriad Genetics position peaked at $3.14M in Q2 2013.
  • 270 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2013.

Based on Northwest & Ethical Investments's 13F filing for Q4 2013, filed 8 Jul 2025.